Market
Scenario
Molecular
modeling has become a valuable and essential tool in the medicinal chemistry
for the drug design process. It describes generation, manipulation or
representation of three-dimensional structures of molecules and their
associated physic-chemical properties. The method is used in drug design,
computational biology, computational chemistry, and materials science. It
involves wide range of computerized techniques based on theoretical chemistry
methods and experimental data to analyze the biological and molecular property.
The major
driving factor for the market are increasing investment of biotechnology and
pharmaceutical industries in R&D, increasing prevalence of different
diseases, and rising need for the better drug treatments. According to the
World Health Organization (WHO), chronic diseases, such as heart disease,
respiratory diseases, cancer, stroke, and diabetes are the leading cause of
mortality across the globe, which represents about 60% of all deaths.
Additionally, 80% of the chronic disease deaths occur in low and middle income
countries. Moreover, technological advancements, growth in the biology and
biosimilars markets, increasing need for the cost effective treatment, and
increasing government support for research & development expected to fuel
the market growth during the forecast period. However, high cost of the research
& development may hamper the market growth during the corresponding period.
The
global molecular modelling market is expected to grow at a CAGR of ~ 15.4 %
during the forecast period 2017-2023.
Key
Players
Some of key the players in the market are Fisher Scientific Company LLC. (US), Indigo Instruments (US), Simulation Plus (US), Certara, L.P. (US), Dassault Systèmes (France), Advanced Chemistry Development (Canada), Schrödinger, LLC (US), Genedata AG (Switzerland), Chemical Computing Group ULC (Canada), Physiomics PLC (UK), and Entelos, Inc. (US).
Some of key the players in the market are Fisher Scientific Company LLC. (US), Indigo Instruments (US), Simulation Plus (US), Certara, L.P. (US), Dassault Systèmes (France), Advanced Chemistry Development (Canada), Schrödinger, LLC (US), Genedata AG (Switzerland), Chemical Computing Group ULC (Canada), Physiomics PLC (UK), and Entelos, Inc. (US).
Intended
Audience
Pharmaceutical
Companies
Research and Development
(R&D) Companies
Biotechnological
Companies
Hospitals and
Clinics
Academic Institutes
and Universities
Segmentations
The global molecular modelling market has been segmented on the basis of approach, application, products, and end user.
The global molecular modelling market has been segmented on the basis of approach, application, products, and end user.
On the basis
of approach, the market is segmented into molecular mechanics approach, and
quantum chemistry approach.
On the
basis of product, the market is segmented into instruments, reagents, kits, and
others.
On the
basis of application, the market is segmented into drug development, drug
discovery, and other application. The drug discovery is further segmented into
direct drug design, indirect drug design, and molecular mimicry. The direct
drug design is sub-segmented into lead identification, target identification,
and others. The indirect drug design is sub-segmented into pharmacophore,
quantitative structure-activity relationships (QSAR), and others.
On the
basis of end user, the market is segmented into pharmaceutical &
biotechnological companies, research organizations, and others.
Regional
Analysis
The Americas dominates the global molecular modelling market owing to well-developed technology, increasing prevalence of the people suffering from cardiovascular diseases, and increasing government support for research & development. Furthermore, high healthcare expenditure and increasing R&D activities have fuelled the growth of the market in this region.
The Americas dominates the global molecular modelling market owing to well-developed technology, increasing prevalence of the people suffering from cardiovascular diseases, and increasing government support for research & development. Furthermore, high healthcare expenditure and increasing R&D activities have fuelled the growth of the market in this region.
Europe
holds the second position in the global molecular modelling market, which is
followed by Asia Pacific. It is expected that the government support for
research & development and availability of funds for research will drive
the market. Asia Pacific is the fastest growing molecular modelling market due
to the presence of rapidly growing economy, developing healthcare technology,
increasing healthcare expenditure, and huge patient pool.
On the
other hand, the Middle East & Africa holds the least share of the market
due to limited availability of medical facilities, less availability of funds,
and poor political conditions in Africa.
Detailed
Table of Contents:
1 Report Prologue
2 Market Introduction
2.1
Definition
2.2
Scope Of The Study
2.2.1
Research Objective
2.2.2
Assumptions
2.2.3
Limitations
3 Research Methodology
3.1
Introduction
3.2
Primary Research
3.3
Secondary Research
3.4
Market Size Estimation
9. Global Molecular Modelling Market, By End User
9.1
Introduction
9.2
Pharmaceutical & Biotechnological Companies
9.3
Research Organizations
9.4
Others
11 Company Landscape
11.1
Introduction
11.2
Market Share Analysis
11.3
Key Development & Strategies
11.3.1
Key Developments
...Continued
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
